FAP, May 11 (FAP)-- the innovative drug plate fluctuated higher, Baili Tianheng rose 15%, and Kangchen Pharmaceutical, Haituang Pharmaceutical, Maiwei Bio, Meike Pharmaceutical, Yifang Bio, and Baiaotai rose more than 5%. On the news side, CITIC Construction Investment Securities said that with policy support and sustained high R & D investment, the number of applications and approvals for domestic drug clinical trials has increased rapidly, innovative R & D enthusiasm has continued, and the innovative drug sector has shown long-term high growth potential.